Company

Sudo Biosciences

https://www.sudobio.com/

Industrybiopharmaceutical company committed to designing and developing precision TYK2 (tyrosine kinase 2) inhibitors

Funding raised

CompanyRoundDate
Sudo BiosciencesSeries B2024-02-13
Sudo BiosciencesSeries B2023-12-20
Sudo BiosciencesSeries A2022-09-29